Atea Pharmaceuticals, Inc.·4

Feb 2, 5:15 PM ET

Foster Wayne 4

4 · Atea Pharmaceuticals, Inc. · Filed Feb 2, 2022

Insider Transaction Report

Form 4
Period: 2022-01-31
Foster Wayne
EVP, Chief Accounting Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-31+120,000120,000 total
    Exercise: $7.14Exp: 2032-01-30Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION